Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12281961 | 1.00 | CA14 (0.46) | CA14CA12DGAT1SMN1; SMN2CA1 | |
| SCHEMBL14593925 | 0.90 | DGAT1 (0.39) | CA14CA12DGAT1SMN1; SMN2CA1 | |
| SCHEMBL14275187 | 0.86 | CA14 (0.43) | CA14CA12DGAT1SMN1; SMN2CA1 | |
| SCHEMBL14275182 | 0.85 | CA14 (0.42) | CA14CA12DGAT1SMN1; SMN2CA1 | |
| SCHEMBL15375593 | 0.83 | CA14 (0.41) | CA14CA12DGAT1SMN1; SMN2CA1 | |
| SCHEMBL15375592 | 0.83 | CA14 (0.41) | CA14CA12DGAT1SMN1; SMN2CA1 | |
| SCHEMBL13946795 | 0.82 | SMN1; SMN2 (0.52) | CA14CA12SMN1; SMN2CA1CA2 | |
| SCHEMBL784551 | 0.82 | SMN1; SMN2 (0.52) | CA14CA12SMN1; SMN2CA1CA2 | |
| Hydrochloric Acid SCHEMBL3023545 | 0.81 | CA14 (0.40) | CA14CA12DGAT1SMN1; SMN2CA1 | |
| SCHEMBL2167963 | 0.81 | CA14 (0.46) | CA14CA12DGAT1SMN1; SMN2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275727-A1 | Peptide turn mimetics | IAPP, GLP1R, VIP | CA14 1119/4885CA12 2437/4885DGAT1 4133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.